Bio-Techne acquires CyVek in $195M deal; Almirall transfers 719 staffers to AstraZeneca;

@FierceBiotech: AstraZeneca builds cancer R&D dream house with $150M Definiens buyout, J&J deal. Article | Follow @FierceBiotech

@JohnCFierce: Joined at the hip. RT @bradloncar: Len Schleifer mentioned Viehbacher axing. he's meeting with Weinberg soon, $REGN very committed to $SNY. | Follow @JohnCFierce

@DamianFierce: I've been off Twitter for a minute. Has anyone called for a $REGN breakup yet? | Follow @DamianFierce

@EmilyMFierce: ICYMI from FierceMedicalDevices: Boston Scientific faces first two federal trials for transvaginal mesh devices. Story | Follow @EmilyMFierce

> Astellas sinks deeper roots into Cambridge's hot R&D field with $1.2B discovery pact. Article

> Rand tallies a whopping $44B in biosimilar drug savings. Item

> Novo Nordisk ($NVO) builds blockbuster case with promising PhIII obesity data. Report

> Bio-Techne is buying CyVek, an immunoassay outfit, for $60 million in cash and up to $135 million in milestones. Story

> Now that it has completed its deal with AstraZeneca ($AZN), Almirall says it is transferring 719 staffers to the Big Pharma. Item

Medical Device News

@FierceMedDev: ReShape finally reveals pivotal obesity data ahead of FDA review. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI yesterday: Covidien sells drug-coated balloon for $30M to appease regulators as it barrels toward Medtronic merger. Article | Follow @VarunSaxena2

@EmilyWFierce: New medical imaging device with scanner the size of an iPhone uses ultrasound chip to create 3-D images in real time. Story from MIT Technology Review | Follow @EmilyWFierce

> ReShape finally reveals pivotal obesity data ahead of FDA review. Story

> Blood loss app developer Gauss Surgical raises $1.5M in equity sale. Article

Pharma News

@FiercePharma: Top-read on FP Monday: AstraZeneca seals the deal for Almirall's respiratory meds. Article | Follow @FiercePharma

@EricPFierce: ICYMI yesterday: The revamp continues at Takeda, as does its financial struggles. Story | Follow @EricPFierce

@CarlyHFierce: ICYMI: Report: Orphan drugs to nab 19% of drug sales by 2020--if payers don't balk, that is. Article | Follow @CarlyHFierce

> Which drugs win the script popularity contest? Crestor, Synthroid and Nexium. Story

> Allergan discloses a secret admirer looking to make an offer. Could it be ... Actavis? More

Biotech Research News

> Three-drug combo kills Ewing sarcoma in mice. More

> Potential target for triple-negative breast cancer found. Story

> 3D stomach tissue grown from human stem cells. Item

> Mouse model shows genetics plays role in Ebola severity. Article

> Drug combo causes lung cancer cells to self-destruct. More

Pharma Manufacturing News

> GSK gets go-ahead for expansion at plant in Scotland. Item

> Forest recalls another 90,000-plus bottles of Bystolic. Report

> Chinese company takes over Boehringer U.S. plant as German drugmaker expands in China. More

> Chairman says Wockhardt has no plans to sell. Story

> Novartis cuts more jobs at U.S. consumer plant ahead of handing it off to GSK. Article

Suggested Articles

Panelists at the CAR-TCR Summit reflected on gender diversity trends and the challenges women face in the life sciences industry.

Loh joins the computational chemistry specialist after a two-year stint at Kymera Therapeutics.

The $3 billion funding boost includes an additional $350 million for targeted Alzheimer’s research.